GoodGuyBill
6 minutes ago
Typical misdirection/FUD move: You don't respond to DCVax being effective, highly scalable, and extensively protected by numerous patents? You say nothing about Merck's most profitable drug, Keytruda (contributing 46% of their total revenue), facing patent expiration in two years? And nothing about